Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501027 | SCV000594987 | likely benign | not specified | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000558382 | SCV000630799 | likely benign | Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001567055 | SCV001790674 | likely benign | not provided | 2021-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001567055 | SCV004156793 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | GLI3: BP4, BP7 |
Prevention |
RCV004535593 | SCV004742534 | likely benign | GLI3-related disorder | 2020-05-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |